Assets تغيير تاريخ
AbbVie USD 136.22B 854M 2023-09
Alnylam Pharmaceuticals USD 3.83B 9.19M 2023-12
Alterity Therapeutics Limited AUD 27.32M 6.07M 2023-06
Amarin USD 839.03M 20.99M 2023-09
Amgen USD 97.15B 6.62B 2023-12
Biogen USD 26.84B 1.35B 2023-12
BioMarin Pharmaceutical USD 6.84B 83.44M 2023-12
CSL USD 36.23B 786.4M 2023-06
Cytokinetics USD 824.32M 83.7M 2023-12
Daiichi Sankyo JPY 2.65T 33.03B 2023-09
Eli Lilly USD 57.92B 3.1B 2023-09
Esperion Therapeutics USD 221.3M 13.32M 2023-09
Geron USD 394.08M 18.94M 2023-12
Grifols EUR 22.06B 631.75M 2023-09
Halozyme Therapeutics USD 1.73B 159.39M 2023-12
Heron Therapeutics USD 229.2M 27.98M 2023-09
Intra Cellular Therapies USD 728.3M 10.63M 2023-12
Ionis Pharmaceuticals USD 2.99B 56.1M 2023-12
Merck USD 106.73B 2.26B 2023-09
Minerva Neurosciences USD 63.13M 4.01M 2023-09
Moderna USD 18.43B 1.02B 2023-12
Nektar Therapeutics USD 442.24M 52.04M 2023-09
Pfizer USD 215.02B 5.15B 2023-09
PTC Therapeutics USD 1.9B 635.81M 2023-12
Regeneron Pharmaceuticals USD 33.08B 916.9M 2023-12
Sarepta Therapeutics USD 3.11B 16.18M 2023-09
United Therapeutics USD 7.17B 143.4M 2023-12
Vanda Pharmaceuticals USD 641.68M 2.85M 2023-06



Esperion Therapeutics الأصول - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Mar 2024.